Experts In cGMP Cell Bank Manufacturing: Maximize The Potential Of Each Tissue Donation

Advanced therapy manufacturing requires reliable cellular starting materials, scalable processes, and regulatory support from development through commercialization. RoosterBio’s CliniControl™ portfolio brings these elements together through off-the-shelf and custom cGMP cell banks, xeno-free expansion media, bioreactor feed, extracellular vesicle collection media, and genetic engineering media. Developers can select low-passage Master Cell Banks for engineering, Working Cell Banks for an accelerated path to clinical manufacturing, or tailored banks built around program-specific requirements. Products are manufactured under ISO-certified quality management systems using controls that comply with current U.S. FDA good manufacturing practices.

Explore available formats, catalog information, testing capabilities, and manufacturing options designed to support clinical programs at commercial scale.